2 Intangible assets
The carrying amount of intangible assets comprises goodwill on the acquisition of the Erber Group in 2020 (€423 million), Crina in 2006 (€9 million) and Pentapharm in 2007 (€32 million). The disposal of subsidiaries relates to the goodwill on NeoResins (€358 million), that was derecognized as part of the divestment of the Resins & Functional Materials (together ‘RFM’) and associated businesses, see Note 3 Change in the scope of the consolidation to the 'Consolidated financial statements’. For full information on these assets including the discussion of the related impairment tests, see Note 8 Intangible assets to the ‘Consolidated financial statements’.
|
|
Goodwill |
|
Under construction |
|
Other |
|
Total |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
Balance at 1 January 2020 |
|
|
|
|
|
|
|
|
Cost |
|
402 |
|
4 |
|
88 |
|
494 |
Amortization and impairment losses |
|
- |
|
- |
|
(66) |
|
(66) |
Carrying amount |
|
402 |
|
4 |
|
22 |
|
428 |
|
|
|
|
|
|
|
|
|
Changes in carrying amount: |
|
|
|
|
|
|
|
|
- Acquisition |
|
423 |
|
- |
|
- |
|
423 |
- Intragroup transfer |
|
- |
|
(4) |
|
(22) |
|
(26) |
|
|
|
|
|
|
|
|
|
Balance at 31 December 2020 |
|
|
|
|
|
|
|
|
Cost |
|
825 |
|
- |
|
- |
|
825 |
Amortization and impairment losses |
|
- |
|
- |
|
- |
|
- |
Carrying amount |
|
825 |
|
- |
|
- |
|
825 |
|
|
|
|
|
|
|
|
|
Changes in carrying amount: |
|
|
|
|
|
|
|
|
- Exchange rate difference |
|
2 |
|
- |
|
- |
|
2 |
- Disposal subsidiaries |
|
(358) |
|
- |
|
- |
|
(358) |
- Impairment |
|
(5) |
|
- |
|
- |
|
(5) |
|
|
|
|
|
|
|
|
|
Balance at 31 December 2021 |
|
464 |
|
- |
|
- |
|
464 |
Cost |
|
469 |
|
- |
|
- |
|
469 |
Amortization and impairment losses |
|
5 |
|
- |
|
- |
|
5 |
Carrying amount |
|
464 |
|
- |
|
- |
|
464 |